Finance

Lists
2196:HKG
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
၁၇.၁၁ HK$
-၀.၂၃%
(-၀.၀၄၀) 1D
အောက် ၁၆, GMT+၈ ၁၆:၀၈:၁၄  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2196...
Open
၁၇.၃၂ HK$
High
၁၇.၅၅ HK$
Low
၁၆.၈၈ HK$
Mkt. cap
ဋေ ၆.၆၅ ထ
Avg. vol.
၃.၆၂ သန်း
Volume
၂.၂၅ သန်း
Dividend
၂.၆၃%
Quarterly dividend
၀.၁၁ HK$
Ex-dividend date
၂၀၂၆ ဇူ ၂၇
P/E ratio
၁၁.၃၃
52-wk high
၂၄.၈၄ HK$
52-wk low
၁၄.၉၀ HK$
EPS
၁.၅၁ HK$
Shares outstanding
၅၅.၁၉ ကုဋေ
No. of employees
၄ သောင်း
Open
၁၇.၃၂ HK$
High
၁၇.၅၅ HK$
Low
၁၆.၈၈ HK$
Mkt. cap
ဋေ ၆.၆၅ ထ
Avg. vol.
၃.၆၂ သန်း
Volume
၂.၂၅ သန်း
Dividend
၂.၆၃%
Quarterly dividend
၀.၁၁ HK$
Ex-dividend date
၂၀၂၆ ဇူ ၂၇
P/E ratio
၁၁.၃၃
52-wk high
၂၄.၈၄ HK$
52-wk low
၁၄.၉၀ HK$
EPS
၁.၅၁ HK$
Shares outstanding
၅၅.၁၉ ကုဋေ
No. of employees
၄ သောင်း
News stories
From web sources and news partners
Foreign Policy Journal
Foreign Policy Journal
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
SoundHound AI (NASDAQ: SOUN) Leads Automation Software Sector In Q2 Earnings Rankings
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၃၆ မိနစ်
Is Intellia Therapeutics (NTLA) Cheap Or Pricey On Its New Chief Medical Officer Appointment?
Stock Traders Daily
Stock Traders Daily
·
ပြီးခဲ့သည့် ၄ နာရီ
Discipline and Rules-Based Execution in NANC Response
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၂ နာရီ
Michael Burry Warns of a Stock Market ‘Supervolcano’
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees၄.၀၇ သောင်း
Founded၁၉၉၄
Headquarters-
Sector-
Last report
၂၀၂၆ ဩ ၂၅
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
ဋေ ၁.၀၄ ထ / ဋေ ၁.၀၇ ထ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
၈.၃၁%
၆.၉၁%
၈.၆၄%
၈.၂၀%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ